Science Corp., a biotech startup specializing in brain-computer interface technology, announced it has raised $230 million in a Series C funding round. Investors include Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT, and Quiet Capital. Since its founding in 2021 by Neuralink co-founder Max Hodak and former Neuralink leader Alan Mardinly, the company has raised $489 million in total. Science Corp. is developing brain and retina implant systems to treat neurological and eye diseases, with plans to expand its clinical trials for its PRIMA BCI retinal implant to additional retinal conditions. The company recently acquired MEMS manufacturing assets to produce neural interface chips in-house, aiming to speed development and reduce costs. This rally of investment highlights the growing interest and competition in neural interface technologies, with other startups like Neuralink, Stairway Medical, and Paradromics also securing significant funding and advancing their technologies.
Back
